Menu

Ann Nolan

Plan For The Perfect Home

“Renovia CEO Marc Beer Raises $42 Million to Advance Care for Female Pelvic Floor Disorders “

Marc Beer, Chief Executive Officer, Chairman, and Co-founder for Renovia Inc, is an expert manager who boasts over 25 years of experience in both commercialization and development in the medical industry. He has overseen the production of products in the pharmaceutical, biotechnology, diagnostic, and device markets of U.S. medical products. Beer also serves as CEO of ViaCell, a specialist biotechnology firm focused on the preservation, collection, and development of umbilical cord stem cells. Marc Beer joined the company back in 2000. Since his involvement, the company has expanded to over 300 employees.

 

In addition to ViaCell and Renovia, Marc Beer is also the founding chairman for the directors’ board of GSGCC, which stands for Good Star Genetics Compensation Committee. He holds the title of founding chairman for the Minerva Neurosciences Inc Audit Committee, or MNIAC. Beer is also a member of the BAC, or Business Advisory Council at Miami University as well the Graduate Studies Research, or GSR, of Notre Dame. Basically, Beer is a big deal in medical circles. Now he is making a splash in the area of women’s health.

 

Recently, Marc Beer raised over $42 million dollars through Renovia for the development of both diagnostic and therapeutic products that treat pelvic floor disorders. Pelvic floor disorders occur when the “hammock” that holds pelvic organs weakens. The results of such a condition lead to urinary incontinence and fecal incontinence. For those at home, this means people develop weak bowels and cannot control their excretions. Urinary incontinence is estimated to affect 250 million women globally. Renovia’s first productfocused on pelvic floor disorders, titled Leva, recently gained FDA approval back in April.

 

A good part of the funding came from the Longwood Fund, which is a healthcare-focused investment firm. Altogether the $42 million will pay for the development of four additional diagnostic and therapeutic products aimed at pelvic floor disorders. Essentially, it is the next phase in the Leva device. The funding will also pay for initial trials of the drugs as well. Beer has high hopes for the investment and recently discussed his view in a public statement.

 

“It is a thrill to have support from healthcare investment leaders in the treatment of the millions of women affected by pelvic floor disorders,” Beer stated. “Together we share a vision of better diagnoses, treatment, and improvement for the millions of women who have pelvic floor disorders.” Renovia will use a digital health platform run off of sensor technology to create new treatment options for female pelvic floor disorders. Hopefully, the next generation of Leva will better equip healthcare providers with solutions to pelvic floor disorders, while lowering the associated long-term healthcare cost that is usually attached. Learn more: https://www.slideshare.net/MarcBeer

 

Marc Beer fights for women with pelvic floor disorders

As time goes by there are a lot of new things coming up in every industry. Improvements have been made in every corner of the world. Talk about how technology has led to new inventions in all fields may it be banking, traveling, how we pay our bills etcetera. The healthcare industry has not been left behind. Technology has been used in the healthcare industry to improve the efficiency of diagnosis, testing, and even treatment. Marc Beer has been associated mainly in the health industry for over 20years, 25 to be precise. Marc Beer experience stretches into biotechnology, devices, pharmaceuticals among others. He has played a part in creating, developing and also develops as a business in such areas of the health industry.

Marc Beer has taken a keen interest in the specific area of the health sector; where he seeks to help patients with a particular form of disorders. By investing in research of drugs that are used in therapy to help cure or alleviate their medical conditions. Marc Beer was at one time the strategic consultant to OvaScience. He also held some positions in Genzyme and also the vice of Global Marketing, he over sighted commercialization of line of drugs for rare disease treatment

In the recent past, Marc Beer raised $42M for a startup with the sole purpose of helping women with pelvic floor disorder. The startup goes by the name Renovia. Marc Beer founded Renovia alongside Ramon Iglesias and Yolanda Lorie back in August of the year 2016. Renovia has attracted the attention of The Longwood Fund which is a firm that invests in healthcare. Longwood made an early investment into Renovia. The funds will go a long way into testing and developing other products and some devices such as the Leva device.

Statistics show that over 250 million women are suffering from the disorder. A person suffering from pelvic floor disorder cannot control the pelvic floor muscles. The pelvic floor supports the organs of the pelvis; the bladder, rectum, uterus or prostate. It causes difficulty in bowel movements. When we talk about an initiative to curb such conditions, it means saving a lot of people from the pain. The Boston based medtech firm is developing diagnostic and therapeutic products. Among the pelvic floor disorders are urinary incontinence. Which as it is an embarrassment that might prove difficult to deal with in women. In the long term, Renovia will strive to find treatments, create awareness and inform people. They also aim at making treatment affordable to all sorts of people.

Marc Beer, a graduate of the Miami University with a bachelor of science degree sits on some boards and consulting roles in several companies. He is the chair for ERYtech Pharma. Learn more: https://www.benzinga.com/pressreleases/18/08/r12237847/osf-ventures-invests-in-company-developing-solutions-for-pelvic-floor-